United States - English - NLM (National Library of Medicine)

ahava dead sea laboratories ltd - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), homosalate (unii: v06sv4m95s) (homosalate - unii:v06sv4m95s), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm) - - helps prevent sunburn

United States - English - NLM (National Library of Medicine)

ahava dead sea laboratories ltd - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), homosalate (unii: v06sv4m95s) (homosalate - unii:v06sv4m95s), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm) - - helps prevent sunburn

United States - English - NLM (National Library of Medicine)

crystalline health & beauty from the dead sea ltd - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - helps eliminate bacteria on hands.

United States - English - NLM (National Library of Medicine)

"crystalline" heath & beauty from the dead sea ltd - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - hand sanitizer to help reduce bacteria that potentially can cause disease, for use when soap and water are not available. 

United States - English - NLM (National Library of Medicine)

crystalline heath & beauty from the dead sea ltd - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer cropscience pty ltd - bacillus amyloliquefaciens strain qst 713 - wettable powder - bacillus amyloliquefaciens strain qst 713 biological-organism active 10.0 cfu/g - fungicide

United States - English - NLM (National Library of Medicine)

takeda pharmaceuticals america, inc. - lanadelumab (unii: 2372v1tkxk) (lanadelumab - unii:2372v1tkxk) - takhzyro® is indicated for prophylaxis to prevent attacks of hereditary angioedema (hae) in adult and pediatric patients aged 2 years and older. none. risk summary there are no available data on takhzyro use in pregnant women to inform any drug associated risks. monoclonal antibodies such as lanadelumab-flyo are transported across the placenta during the third trimester of pregnancy; therefore, potential effects on a fetus are likely to be greater during the third trimester of pregnancy. an enhanced pre-and postnatal development (eppnd) study conducted in pregnant monkeys at doses resulting in exposures of up to 33 times the exposure achieved (on an auc basis) at the maximum recommended human dose (mrhd) revealed no evidence of harm to the developing fetus. the background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15

Australia - English - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - lanadelumab, quantity: 300 mg - injection, solution - excipient ingredients: citric acid monohydrate; water for injections; dibasic sodium phosphate dihydrate; polysorbate 80; histidine; sodium chloride - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (c1-esterase-inhibitor deficiency or dysfunction) in patients aged 12 years and older.

New Zealand - English - myHealthbox

bayer ag - suspension concentrate - biologics

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

qpharma pty ltd - denatonium benzoate - topical spray & lotion - denatonium benzoate carbamate active 200.0 mg/l - dermatological preps. - dog | bitch | castrate | puppy - discourage chewing, biting etc | discourage biting bandage | discourage biting crib | discourage biting rug | discourage biting stable inter | discourage biting tail | discourage biting wood